Pauls Stradiņš Clinical University Hospital is an outpatient and hospital health care service provider in Riga, Latvia. This hospital also plays a role in medical science and medical education.

There are 840 beds in Pauls Stradins Clinical University Hospital.

During the past decade, Pauls Stradins Clinical University Hospital conducted 115 clinical trials. In the 10-year time frame, 115 clinical trials started and 48 clinical trials were completed, i.e. on average, 41.7% percent of trials that started reached the finish line to date. In the past 5 years, 48 clinical trials started and 33 clinical trials were completed. i.e. 68.8% of trials that started reached the finish line.

Out of the total clinical trials conducted in "Pauls Stradins Clinical University Hospital" #1 sponsor was "Hoffmann-La Roche" with 12 trials, followed by "Boston Scientific Corporation" with 9 trials sponsored, "Celgene" with 9 trials sponsored, "Biotronik SE & Co. KG" with 7 trials sponsored and "Bayer" with 7 trials sponsored. Other sponsors include 115 different institutions and companies that sponsored additional 85 trials in total.

In terms of collaborators to trials, out of the total clinical trials conducted in "Pauls Stradins Clinical University Hospital" #1 collaborator was "Arena is a wholly owned subsidiary of Pfizer" with 2 trials as a collaborator, "MLM Medical Labs GmbH" with 2 trials as a collaborator, "Massachusetts General Hospital" with 2 trials as a collaborator, "nabios GmbH" with 2 trials as a collaborator and "ADIR, a Servier Group company" with 1 trials as a collaborator. Other collaborators include 38 different institutions and companies that were collaborators in the rest 48 trials.

According to Clinical.Site data, the most researched conditions in "Pauls Stradins Clinical University Hospital" are "Coronary Artery Disease" (16 trials), "Ulcerative Colitis" (14 trials), "Heart Failure" (8 trials), "Crohn Disease" (7 trials) and "Atrial Fibrillation" (5 trials). Many other conditions were trialed in "Pauls Stradins Clinical University Hospital" in a lesser frequency.

Most popular intervention types in "Pauls Stradins Clinical University Hospital" are "Drug" (103 trials), "Device" (44 trials), "Other" (16 trials), "Biological" (9 trials) and "Procedure" (5 trials). Other intervention types were less common.

The name of intervention was led by "Placebo" (40 trials), "Paclitaxel" (5 trials), "Aflibercept" (4 trials), "Etrolizumab" (4 trials) and "Ozanimod" (4 trials). Other intervention names were less common.

The vast majority of trials in "Pauls Stradins Clinical University Hospital" are 152 trials for "All" genders, 7 trials for "Male" genders and 4 trials for "Female" genders.

Currently, there are NaN active trials in "Pauls Stradins Clinical University Hospital". undefined are not yet recruiting, 30 are recruiting, 23 are Active, not recruiting, and undefined are Enrolling by invitation. In total, there were 80 completed trials in Pauls Stradins Clinical University Hospital, undefined suspended trials, and 21 terminated clinical trials to date.

Out of the total trials that were conducted in Pauls Stradins Clinical University Hospital, 5 "Phase 1" clinical trials were conducted, 30 "Phase 2" clinical trials and 74 "Phase 3" clinical trials were conducted as well. "Phase 4" trials included 10 trials, and there were also 28 trials that are defined as “Not Applicable".